288 related articles for article (PubMed ID: 17118837)
1. Endocrine ophthalmopathy and radioiodine therapy.
Karlsson FA
Acta Oncol; 2006; 45(8):1046-50. PubMed ID: 17118837
[TBL] [Abstract][Full Text] [Related]
2. Graves' ophthalmopathy and 131I therapy.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
[TBL] [Abstract][Full Text] [Related]
3. Do glucocorticoids affect outcome in Graves' disease following radioiodine therapy?
Salvatore D; Fenzi G
Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):194-5. PubMed ID: 16932282
[No Abstract] [Full Text] [Related]
4. Thyroid associated orbitopathy--medication, radioiodine or operation?
Czarnywojtek A; Zgorzalewicz-Stachowiak M; Stangierski A; Florek E; Zdanowska J; Katarzyna H; Andrzejewska M; Ruchała M
Przegl Lek; 2012; 69(10):1140-3. PubMed ID: 23421110
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine therapy and thyroid-associated orbitopathy: risk factors and preventive effects of glucocorticoids.
Dietlein M; Dederichs B; Weigand A; Schicha H
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S190-4. PubMed ID: 10614920
[TBL] [Abstract][Full Text] [Related]
6. [Current understanding of pathogenesis of Graves ophthalmopathy].
Ando T; Eguchi K
Nihon Rinsho; 2006 Dec; 64(12):2275-8. PubMed ID: 17154091
[TBL] [Abstract][Full Text] [Related]
7. [Paradoxical effect of radioiodine therapy in functional thyroid autonomy and mild immunothyropathy].
Dunkelmann S; Rudolph F; Prillwitz A; Groth P; Schümichen C
Nuklearmedizin; 1998 Jan; 37(1):23-9. PubMed ID: 9467166
[TBL] [Abstract][Full Text] [Related]
8. The tale of radioiodine and Graves' orbitopathy.
Ponto KA; Zang S; Kahaly GJ
Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895
[TBL] [Abstract][Full Text] [Related]
9. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
[TBL] [Abstract][Full Text] [Related]
10. Grave's Eye disease developing following radioiodine treatment for toxic nodular goitre.
Tahrani AA; Rangan S; Moulik P
Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):471-3. PubMed ID: 17647147
[TBL] [Abstract][Full Text] [Related]
11. Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis.
Vannucchi G; Campi I; Covelli D; Dazzi D; Currò N; Simonetta S; Ratiglia R; Beck-Peccoz P; Salvi M
J Clin Endocrinol Metab; 2009 Sep; 94(9):3381-6. PubMed ID: 19567525
[TBL] [Abstract][Full Text] [Related]
12. Graves' ophthalmopathy in patients treated with radioiodine 131-I.
Bałdys-Waligórska A; Gołkowski F; Kusnierz-Cabala B; Buziak-Bereza M; Hubalewska-Dydejczyk A
Endokrynol Pol; 2011; 62(3):214-9. PubMed ID: 21717402
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA
Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701
[TBL] [Abstract][Full Text] [Related]
14. Identification of a subgroup of Graves' disease patients at higher risk for severe ophthalmopathy after radioiodine.
Barth A; Probst P; Bürgi H
J Endocrinol Invest; 1991 Mar; 14(3):209-12. PubMed ID: 2071823
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study.
Vannucchi G; Covelli D; Campi I; Currò N; Dazzi D; Rodari M; Pepe G; Chiti A; Guastella C; Lazzaroni E; Salvi M
Thyroid; 2019 Dec; 29(12):1828-1833. PubMed ID: 31860407
[No Abstract] [Full Text] [Related]
16. Comparative Efficacy of Four Treatments in Patients with Graves' Disease: a Network Meta-analysis.
Ren Z; Qin L; Wang JQ; Li Y; Li J; Zhang RG
Exp Clin Endocrinol Diabetes; 2015 May; 123(5):317-22. PubMed ID: 25988881
[TBL] [Abstract][Full Text] [Related]
17. Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safe.
Rosetti S; Tanda ML; Veronesi G; Masiello E; Premoli P; Gallo D; Cusini C; Donati S; Sabatino J; Ippolito S; Piantanida E; Bartalena L
J Endocrinol Invest; 2020 Mar; 43(3):381-383. PubMed ID: 31587179
[No Abstract] [Full Text] [Related]
18. Post-radioiodine De Novo Onset Graves' Ophthalmopathy: Case Reports and a Review of the Literature.
Batra R; Krishnasamy SK; Buch H; Sandramouli S
Semin Ophthalmol; 2015 May; 30(3):227-31. PubMed ID: 24409943
[TBL] [Abstract][Full Text] [Related]
19. Radioiodine therapy of Graves' hyperthyroidism in patients without pre-existing ophthalmopathy: can glucocorticoids prevent the development of new ophthalmopathy?
Dederichs B; Dietlein M; Jenniches-Kloth B; Schmidt M; Theissen P; Moka D; Schicha H
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):366-70. PubMed ID: 16915539
[TBL] [Abstract][Full Text] [Related]
20. Does radioiodine cause the ophthalmopathy of Graves' disease?
McDougall IR
Nucl Med Commun; 1993 Feb; 14(2):79-81. PubMed ID: 8429998
[No Abstract] [Full Text] [Related]
[Next] [New Search]
